Status Report to the Board of Governors. PCORI Dissemination Workgroup. Can You Hear Us Now?

Similar documents
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI)

From Evidence to Practice: Making CER Findings Work for Providers and Patients

Introduction Patient-Centered Outcomes Research Institute (PCORI)

Rapid-Learning Healthcare Systems

Comparative Effectiveness Research and Patient Centered Outcomes Research in Public Health Settings: Design, Analysis, and Funding Considerations

The Role of AHRQ in Comparative Effectiveness Research

Institute of Medicine Standards for Systematic Reviews

The Influence of Health Policy on Clinical Practice. Dr. Kim Kuebler, DNP, APRN, ANP-BC Multiple Chronic Conditions Resource Center

RESPONSE TO QUESTIONS SUBMITTED FOR TIER I CYCLE 1 PIPELINE TO PROPOSAL AWARDS

21 st Century Health Care: The Promise and Potential of a Learning Health System

Inaugural Town Hall Cycle February 11, 2016

Dissemination, Uptake, and Impact: Evaluation at PCORI Rachel Witsaman, MPH, PMP

PCORI s Approach to Patient Centered Outcomes Research

On April 19, 2007, the National Working Group on

HEALTHCARE 20/20: LEARNING FORWARD

PCORI grants: dos and don ts from a reviewer s perspective. Margaret Olsen, PhD, MPH March 4, 2014

ABMS Organizational QI Forum Links QI, Research and Policy Highlights of Keynote Speakers Presentations

As to diseases make a habit of two things - to help, or at least, to do no harm.

METHODOLOGY. Transparency. Conflicts of Interest. Multidisciplinary Steering Committee Composition. Evidence Review

Peer Review at PCORI. August 26, 2013

AHRQ Career Development Programs: Opportunities, Tips, and Mock Review

A Comparative Effectiveness Trial Warfarin versus Direct Oral Anti- Coagulants. Thomas L. Ortel, M.D., Ph.D. 2 December 2016

The Physicians Foundation Strategic Plan

Dashboard Review First Quarter of FY-2017 Joe Selby, MD, MPH

Six Key Principles for the Efficient and Sustainable Funding & Reimbursement of Medical Technologies

Executive Director s Report. Joe Selby, MD, MPH, Executive Director PCORI Board of Governors Meeting Washington, DC September 23, 2013

Health IT Council and Advisory Committee Meeting. June 18, 2012 One Ashburton Place, 21 st Floor Boston, MA

The STAAR Initiative

The Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System

The National Action Plan to Improve Health Literacy

Tier A Cycle 1 Pipeline to Proposal Awards Application Guidelines. Published March 1, 2017

Questions for the Patient-Centered Outcomes Research Institute Peer Review Process Webinar (8/26/13)

Care Coordination is more than a Care Coordinator: Translating Research to Practice in Rural

What s Next: People-Powered Knowledge Generation from Digital Data

Cognitive Level Certified Professional in Patient Safety Detailed Content Outline Recall. Total. Application Analysis 1.

The Key Principles And Characteristics Of An Effective Hospital Medicine Group

KNOWLEDGE SYNTHESIS: Literature Searches and Beyond

Quality Standards. Process and Methods Guide. October Quality Standards: Process and Methods Guide 0

The Role of Health IT in Quality Improvement. P. Jon White, MD Health IT Director Agency for Healthcare Research and Quality

Artificial Intelligence Changes Evidence Based Medicine A Scalable Health White Paper

2014 MASTER PROJECT LIST

Health Technology Assessment (HTA) Good Practices & Principles FIFARMA, I. Government s cost containment measures: current status & issues

Accountable Care: Clinical Integration is the Foundation

Overview of a new study to assess the impact of hospice led interventions on acute use. Jonathan Ellis, Director of Policy & Advocacy

The Minnesota Statewide Quality Reporting and Measurement System (SQRMS)

Global Health Evidence Summit. Community and Formal Health System Support for Enhanced Community Health Worker Performance

Foundations - Open Grant Opportunities

TBIMS Committees, Modules and Special Interest Groups

National Patient-Centered Clinical Research Network Coordinating Center

Linda Pruitt, RN, MS Associate Professor Eastern Shore Community College Member VCCS PDC Committee Chairperson of Grants Sub-Committee

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

National Multiple Sclerosis Society

Post-Professional Doctor of Occupational Therapy Advanced Practice Track

Chapter 2: Evidence-Based Nursing Practice

LESSONS LEARNED IN LENGTH OF STAY (LOS)

Definition of Meaningful Use of Certified EHR Technology for Hospitals Approved by the HIMSS Board of Directors April 24, 2009

Experiential Education

Big data in Healthcare what role for the EU? Learnings and recommendations from the European Health Parliament

DCF Special Policy Dialogue THE ROLE OF PHILANTHROPIC ORGANIZATIONS IN THE POST-2015 SETTING. Background Note

Population Health Management Tools and Strategies to Support Care Coordination An InfoMC White Paper April 2016

NIHR Funding For further assistance with NIHR funding please contact the Protocol Development Service

Friends of AHRQ Briefing

Achieving scale up in healthcare quality provision: Case study from Ghana Nneka Mobisson-Etuk Institute for Healthcare Improvement (IHI)

High Level Pharmaceutical Forum

DOCUMENT E FOR COMMENT

Patient -Centered Comparative Effectiveness Research and Quality Improvement: Their Relationship in Transformative Research

Registry of Patient Registries (RoPR) Policies and Procedures

Learning Briefs: Equity in Specialty Care

Leveraging Health Care IT Investment

Post-Professional Doctor of Occupational Therapy Elective Track in Aging

Post-Professional Doctor of Occupational Therapy Elective Track in Administration and Practice Management

MINISTRY OF HEALTH PATIENT, P F A A TI MIL EN Y, TS C AR AS EGIVER PART AND NER SPU BLIC ENGAGEMENT FRAMEWORK

Control: Lost in Translation Workshop Report Nov 07 Final

Quality Improvement in the Advent of Population Health Management WHITE PAPER

W. Douglas Weaver, MD, MACC. American College of Cardiology SENATE FINANCE COMMITTEE

June 22, Leah Binder President and CEO The Leapfrog Group 1660 L Street, N.W., Suite 308 Washington, D.C Dear Ms.

Copyright 2011 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.

Person-Centered Accountable Care

The Strategic Plan of the American College of Clinical Pharmacy 1

LEGISLATIVE REPORT NORTH CAROLINA HEALTH TRANSFORMATION CENTER (TRANSFORMATION INNOVATIONS CENTER) PROGRAM DESIGN AND BUDGET PROPOSAL

Review of DNP Program Curriculum for Indiana University Purdue University Indianapolis

2018 Annual Research Meeting (ARM) Conference Theme Areas of Focus

School of Nursing Philosophy (AASN/BSN/MSN/DNP)

SUMMARY: The U.S. Department of Energy s (DOE or the Department) Clean Energy

The Certification Commission for Healthcare Information Technology (CCHIT) -- Overview and Perspective --

ONTARIO PATIENT ORIENTED RESEARCH STRATEGY: Patient Reported Outcome-informed Innovation

Model of Care Scoring Guidelines CY October 8, 2015

Product and Network Innovation: Strategies to Achieve Triple Aim Success. Patrick Courneya, MD Medical Director, HealthPartners October 31, 2013

CERTIFICATE OF NEED (CON) REGULATION General Perspectives Maryland Perspectives

Pfizer Independent Grants for Learning & Change Request for Proposals (RFP) Antimicrobial Stewardship in the Asia-Pacific Region

The John J. Conger Lecture Child Health Services in a Post Affordable Care Act World: What Do We Need to Know?

Fostering Effective Integration of Behavioral Health and Primary Care in Massachusetts Guidelines. Program Overview and Goal.

C. Agency for Healthcare Research and Quality

Ministerial declaration of the high-level segment submitted by the President of the Council

Clinical Development Process 2017

CPC+ CHANGE PACKAGE January 2017

Ethics for a learning health care system: The Common Purpose Framework. Nancy E. Kass, ScD Johns Hopkins Berman Institute of Bioethics

Are physicians ready for macra/qpp?

Background and Context:

OptumRx: Measuring the financial advantage

Transcription:

Status Report to the Board of Governors PCORI Dissemination Workgroup Can You Hear Us Now? PCORI Board of Governors Jacksonville, Florida January 2012 1

Members of the Workgroup Carolyn Clancy, Co-Chair Sharon Levine, Co-Chair Lawrence Becker Allen Douma Howard Holland Gail Hunt Freda Lewis-Hall Steve Lipstein Brian Mittman Robin Newhouse Grayson Norquist Jean Slutsky 2

Legislation (c) PURPOSE. The purpose of the Institute is to assist patients, clinicians, purchasers, and policy-makers in making informed health decisions.and the dissemination of research findings with respect to the relative health outcomes, clinical effectiveness, and appropriateness of the medical treatments, services, and items described in subsection (a)(2)(b). (1) DISSEMINATION. The Office of Communication and Knowledge Transfer (referred to in this section as the Office ) at the Agency for Healthcare Research and Purpose Quality (or any other relevant office designated by Agency for Healthcare Research and Quality), in consultation with the National Institutes of Health, shall broadly disseminate the research findings that are published by the Patient Centered Outcomes Research Institute established under section 1181(b) of the Social Security Act (referred to in this section as the Institute ) and other governmentfunded research relevant to comparative clinical effectiveness research. The Office shall create informational tools that organize and disseminate research findings for physicians, health care providers, patients, payers, and policy makers. The Office shall also develop a publicly available resource database that collects and contains government-funded evidence and research from public, private, not-for profit, and academic sources. 3 Source: Affordable Care Act. Subtitle D Patient-Centered Outcomes Research. PUBLIC LAW 111 148 MAR. 23, 2010.

Timeline of Activities Formal launch of WG RAND Presentation to WG (12/1) Oct Nov Dec Jan 2011 2011 2011 2012 AHRQ Presentation to WG (10/26) WG three-hour teleconference (1/6) 4

PCORI Dissemination Assumptions Success for PCORI and AHRQ = impact on practice and patient outcomes PCORI will disseminate results of PCORI-funded and conducted research and PCORI will also fund research on dissemination, but will complement and supplement what AHRQ/NIH are doing, not duplicate efforts PCORI has unique opportunities and leg requirements Dissemination is essential and requires investment, which could occur in multiple ways: Encourage / require dissemination accelerating components in all PFAs 5 Provide rapid follow-on funding for dissemination for selected studies

PCORI Dissemination Assumptions (cont d) PCORI has a related role and opportunity in creating demand for, and receptivity to, PCOR in anticipation of evidence/research findings Not a one-size fits all endeavor translating results, and influencing behavior, is context-dependent PCORI will be most effective by establishing partnerships early (with AHRQ, NIH, NGO s and private sector actors) and clarifying what PCORI will and will not do Effective patient and stakeholder engagement, early on in the research endeavor, is the first step in planning and executing dissemination, and facilitating uptake 6

First Steps: Learning from the Work of Others Defining successful dissemination and potential obstacles/barriers to success Identifying dissemination activities of other organizations, namely AHRQ, to determine potential gaps that PCORI may fill Lessons learned from dissemination studies that may be relevant to PCORI activities Brainstorming strategies and assumptions to review with the Board of Governors, to inform PCORI s Dissemination Framework and Strategy 7

New England Healthcare Institute (NEHI) Existing Hurdles to Evidence Dissemination in the Health Care System Limitations of the scientific evidence Constraints on practicing clinicians Gaps in the medical evidence due to the limits of scientific knowledge, limitations of study design, or both Little or no time to consult evidence or colleagues, limited reimbursement for consulting evidence, and limited skills among some clinicians for consulting electronic data sources Constraints on patients Limited understanding of health care issues among many patients, and limited capabilities to make health care choices comprehensible to patients Limited incentives for clinicians to change practices Limitations in the presentation of evidence Limited access to evidence Lack of (or weakness of) financial and professional incentives for clinician attention to evidence-based guidelines/adherence to protocols, clinician distrust of an over-reliance on evidence ( cookbook medicine ), and organizational inertia Unclear presentation, inconvenient formats, and lack of clear rationale for action by the clinician or patient Uneven distribution of health care IT infrastructure and other resources that make evidence available in convenient forms 8 Source: From Evidence to Practice: Making CER Findings Work for Providers and Patients. Sept. 2010. http://www.nehi.net/publications/47/from_evidence_to_practice_making_cer_findings_work_for_providers_and_patients

New England Healthcare Institute (NEHI) Anticipated hurdles to CER Dissemination: The public perception of CER and its legitimacy, including clinicians trust in systematic reviews and observational studies Lack of standard methodologies Speed of change in the evidence base Strength of evidence Heterogeneity of treatment effects Drivers of CER Dissemination: The Learning Health Care System concept and the contextualization of evidence Patient-centered health care Mass media 9 Source: From Evidence to Practice: Making CER Findings Work for Providers and Patients. Sept. 2010. http://www.nehi.net/publications/47/from_evidence_to_practice_making_cer_findings_work_for_providers_and_patients

New England Healthcare Institute (NEHI) Use consistent evidence ratings Create partnerships with stakeholder groups Select high priority targets for dissemination Building a Coherent Strategy For Dissemination Policy Choices Integrate CER dissemination into the deployment of health care IT Utilize patient and clinician incentives to promote comparative clinical effectiveness Communicate directly with the public and with patients Note: The WG acknowledges that there is an engine in place (AHRQ) to address some of these issues, and there are required activities established under legislation 10 Source: From Evidence to Practice: Making CER Findings Work for Providers and Patients. Sept. 2010. http://www.nehi.net/publications/47/from_evidence_to_practice_making_cer_findings_work_for_providers_and_patients

AHRQ s PCOR Activities Goals Dissemination, translation, and implementation goals include fostering awareness and use of PCOR, informing professional and consumer audiences about AHRQ s Effective Healthcare Program, and driving towards a greater degree of shared decision-making Target Audience Effective Health Care (EHC) Program Audience is broad and includes healthcare providers, consumers, patients, caregivers, decision makers, policymakers, business leaders, and advocates Audiences are diverse and information needs to be framed differently for different audiences EHC offers continuing education and other resources, and does a robust job of developing and testing various formats (received $300 M for PCOR activities under ARRA) Emphasis on user-driven synthesis; has produced more than 100 products for clinicians, patients and families, and policy makers EHC conducts research on dissemination and partnerships 11 Source: Overview of AHRQ s ARRA-Funded PCOR Activities. Oct 2011. http://www.nehi.net/publications/47/from_evidence_to_practice_making_cer_findings_work_for_providers_and_patients

AHRQ s PCOR Activities Community Forum Project iadapt Dissemination Contracts Its purpose is to improve and expand public and stakeholder engagement in PCOR or CER It will identify useful and effective ways to engage stakeholders and the general public in AHRQ Programs Develop innovative ways to adapt and disseminate summary guides for health consumers Supports Clinical Decision Support Systems, Culturally Tailored/Health Literacy, Communication/Marketing, Academic Detailing/CME Support national awareness building, establishment of regional partnerships, providing online continuing education, conducting academic detailing, and a systematic program evaluation 12 Evaluation Evaluate effectiveness of publicity centers, regional offices, continuing education, and academic detailing Determine the level of awareness, understanding, behavior change/use, and benefits of PCOR among targeted audiences Source: Overview of AHRQ s ARRA-Funded PCOR Activities. Oct 2011. http://www.nehi.net/publications/47/from_evidence_to_practice_making_cer_findings_work_for_providers_and_patients

Important Take-Away Messages for PCORI 13 Programs are most successful when they are audience-centered and use the audiences preferred formats and channels Credentials are important in gaining access to healthcare providers Health plans, health systems, and large medical groups are valuable sources of access to clinicians Clinicians want unbiased and balanced information from a trusted and credible source Disseminating new research differs from disseminating systematic reviews

RAND Briefing to PCORI RAND Study Objectives 1. Developing a Dissemination Framework for assessing barriers and enablers to CER translation into practice 2. Identifying barriers to and enhancers of CER translation 3. Developing recommendations for more effective CER translation 14

RAND Briefing to PCORI 15 Case Study Topics and Results CATIE: Conventional antipsychotics had similar effectiveness and side effects vs. atypical antipsychotics COURAGE: Optimal medical therapy (OMT) provided equivalent survival benefit and comparable relief of angina to OMT + Percutaneous Coronary Intervention COMPANION: Compared to optimal medical therapy, both cardiac resynchronization therapy (CRT) and CRT + defibrillator reduced hospitalization rates, improved functional status, and improved survival SPORT: Surgery for lumbar spinal stenosis had better outcomes than non-operative treatment in a cohort study CPOE: Computerized Physician Order Entry significantly reduced the incidence of serious medication errors vs. paper-based entry

RAND Briefing to PCORI: Conceptual Framework Based upon literature review/environmental scan, RAND developed a conceptual framework that included four phases of translation 16 Source: Dissemination and Adoption of CER Findings when Findings Challenge Current Practices. Dec 2011

RAND Briefing to PCORI Study Findings Little to no practice change, even when interventions were favored by results (i.e., implementation of results would have resulted in more aggressive or expansive practice). For each of 5 studies, RAND assessed factors that prevented or slowed uptake into practice and root causes of incomplete translation were identified. Misalignment of financial incentives Ambiguity of CER results Cognitive biases Failure to address the needs of end users Inadequate use of decision support by patients and clinical professionals 17

Important Take-Away Messages for PCORI Potential for CER results to influence practice is not yet fully realized Current translation process is still ad hoc and post hoc with some exceptions Significant barriers to CER translation may be addressed through a variety of policy levers, namely building CER-enabling infrastructure with a focus on governance, standards, financing, appeals to professionalism, education and marketing, and research and evaluation Prospective studies of the CER translation process based on the proposed framework could guide future improvements 18

Important Take-Away Messages for PCORI (cont d) CER results are sometimes outdated by the time the study ends is there a way to get answers faster? Current under-appreciation for the roles of specialty societies in changing clinical practice Additional information on best practices, but also the rate of diffusion, is needed Need to create demand on the front end this could be written into PCORI solicitations PCORI may want to engage cognitive psychologists 19

Developing an Overall Framework: Strategic Issues Raised by Presentations 20 How can PCORI, building on AHRQ s work, also work to address the black box between dissemination and uptake identified by RAND? Several of the areas identified by RAND for additional infrastructure focus are areas where PCORI could be involved: generation of CER; more effective translation; evaluation of impact; transparent governance Can we learn from examples of where translation works well? Can we prospectively study both infrastructure and sociological factors that make things work? How do we incorporate elements that work into design?

Developing an Overall Framework: Strategic Issues Raised by Presentations (cont d) 21 How do we set up a platform for dissemination that works and allows us to customize strategy to meet the needs of different audiences, given audience heterogeneity (diverse research, multilevel and multidimensional barriers, channels for dissemination)? What can be required components of all funding announcements that can accelerate dissemination e.g., requirement for stakeholder engagement in a strategic and planned way? Can we provide additional, follow-on funding for dissemination and implementation when studies have meaningful findings? How to anticipate and address potential resistance early in process?

PCORI Dissemination Assumptions Success for PCORI and AHRQ = impact on practice and patient outcomes PCORI will disseminate results of PCORI-funded and conducted research and PCORI will also fund research on dissemination, but will complement and supplement what AHRQ/NIH are doing, not duplicate efforts PCORI has unique opportunities and leg requirements Dissemination is essential and requires investment, which could occur in multiple ways: Encourage / require dissemination accelerating components in all PFAs 22 Provide rapid follow-on funding for dissemination for selected studies

PCORI Dissemination Assumptions (cont d) PCORI has a related role and opportunity in creating demand for, and receptivity to, PCOR in anticipation of evidence/research findings Not a one-size fits all endeavor translating results, and influencing behavior, is context-dependent PCORI will be most effective by establishing partnerships early (with AHRQ, NIH, NGO s and private sector actors) and clarifying what PCORI will and will not do Effective patient and stakeholder engagement, early on in the research endeavor, is the first step in planning and executing dissemination, and facilitating uptake 23

Next Steps Feedback from the Board at early stage (today; via COEC and PDC ongoing) Building a framework for PCORI dissemination Commissioning landscape review Articulating potential dissemination acceleration components for PFA s released in May, 2012 24